Covid
WHO’s Covaxin clearance delayed further: Reports
According to sources and reports, the World Health Organization (WHO) has further delayed the emergency use authorisation (EUA) for Covaxin, as the global body has sent more technical queries to its manufacturer Bharat Biotech, according to sources.
Covaxin will not be considered an accepted vaccine by most countries around the world without EUA.
WHO’s queries for Bharat Biotech comes despite the Hyderabad-based drug maker asserting that it has submitted all data required for clearance.